Project Details
Description
NRG-GU012: Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)
| Status | Finished |
|---|---|
| Effective start/end date | 3/20/25 → 6/18/25 |
Funding
- NRG ONCOLOGY FOUNDATION, INC.
- NIH NATIONAL CANCER INSTITUTE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.